Seems like it sold at ~ 20x EBITDA and a little over 2x sales. Expensive by the first metric; cheap by the second. Revenue is ~180k per employee - low for an

Seems like it sold at ~ 20x EBITDA and a little over 2x sales. Expensive by the first metric; cheap by the second. Revenue is ~180k per employee - low for an established company. The weak EBITDA makes or tough buy for a PE firm, who might not be able to make interest payments on the debt required for a purchase. This is much less of an issue for IBM who would pay in cash. I see IBM making half the employees redundant an then pushing the product through their existing sales network. Not a bad deal for them, though it might make Algo a tougher place to work.